guanosine-triphosphate and Retroviridae-Infections

Ras proteins play a major role in human cancers but have not yielded to therapeutic attack. Ras-driven cancers are among the most difficult to treat and often excluded from therapies. The Ras proteins have been termed "undruggable," based on failures from an era in which understanding of signaling transduction, feedback loops, redundancy, tumor heterogeneity, and Ras' oncogenic role was poor. Structures of Ras oncoproteins bound to their effectors or regulators are unsolved, and it is unknown precisely how Ras proteins activate their downstream targets. These knowledge gaps have impaired development of therapeutic strategies. A better understanding of Ras biology and biochemistry, coupled with new ways of targeting undruggable proteins, is likely to lead to new ways of defeating Ras-driven cancers.

Topics: Animals; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Mice; Neoplasms; Oncogene Protein p21(ras); Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Retroviridae Infections; Signal Transduction; Tumor Virus Infections